Tilray Medical Study Shows Promise of Cannabis in Fibromyalgia Treatment

A new study by Tilray Medical, a division of Tilray Brands, shows positive results in using cannabinoid treatments for patients with fibromyalgia. The study, titled ‘Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms: A Case Series (TOMAS),’ examined the impact of Tilray Dried Flower THC18 on chronic pain, sleep, and quality of life. The findings suggest that cannabinoids could be a promising and cost-effective treatment option for fibromyalgia patients.

The Ethical Dilemma of Animal Testing in Medical Research

Animal testing is a crucial part of medical research, but its effectiveness is often questioned. A new study reveals a shockingly low success rate of animal-tested therapies in humans, raising concerns about the ethical balance between advancing medicine and animal welfare. The study suggests improvements in animal research methods, along with alternative approaches, could lead to more efficient and ethical research.

Patients Treated by Female Doctors Fare Better, Study Finds

Patients treated by female physicians in the U.S. have lower mortality and readmission rates compared to those treated by male physicians, according to peer-reviewed research published in the Annals of Internal Medicine. The study analyzed data from over 700,000 Medicare patients aged 65 or older hospitalized between 2016 and 2019. The researchers found that just under a third of the female patients were treated by female physicians, and while there were no significant differences in key metrics like length of stay and spending, both male and female patients treated by female physicians had lower death and readmission rates. The researchers suggest that factors such as better communication skills and a more patient-centered approach may contribute to these findings.

Jeremy Paxman Reveals Assisted Suicide Considerations and Donates Brain for Parkinson’s Research

Former University Challenge host Jeremy Paxman has opened up about his battle with Parkinson’s disease, disclosing that he has considered assisted suicide and is donating his brain for research. Paxman was diagnosed in 2021 and has experienced worsening symptoms over time, including slow movement, involuntary shaking, and memory loss. While expressing sympathy for those who choose to end their lives through assisted suicide, Paxman has ruled out the option for himself due to hygiene concerns he observed at a Swiss clinic. Despite his personal stance, he respects the choices of others and supports their right to make autonomous decisions regarding their end-of-life care.

Scroll to Top